ADC Therapeutics SA
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC

Abstract:

The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to administration of ADCs which bind to CD19 (CD19-ADCs).